Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fycompa
Pharma
Eisai lays off 91 staffers on its Fycompa team in the US
With an approval for Leqembi under its belt, Eisai is doubling down on Alzheimer’s—and that means cuts elsewhere along the firm's neuroscience team.
Fraiser Kansteiner
Feb 3, 2023 7:06am
Eisai peddles US rights to epilepsy drug Fycompa to Catalyst
Dec 20, 2022 10:35am
Already a hated pricing foe, Germany eyes stiff new controls
Nov 14, 2016 10:53am
